NASDAQ$MEDP

Medpace Holdings Inc. · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Reported third quarter results with revenue increasing, net new business awards rising, and GAAP net income improving.

Medpace Holdings, Inc. announced financial results for the third quarter ended September 30, 2020. Revenue increased by 6.5% to $230.4 million compared to the prior-year period. Net new business awards were $315.4 million, and GAAP net income was $41.5 million, or $1.09 per diluted share.

  • Revenue for the third quarter of 2020 increased 6.5% to $230.4 million.
  • Net new business awards increased 10.5% to $315.4 million, resulting in a net book-to-bill ratio of 1.37x.
  • GAAP net income for the third quarter of 2020 was $41.5 million, or $1.09 per diluted share.
  • EBITDA for the third quarter of 2020 increased 49.4% to $51.9 million.

Headline financials

Total Revenue

$230M

Previous: $216M+6.5%
EPS (adj)

$1.09

Previous: $0.71+53.5%
Net New Business Awards

$315M

Previous: $285M+10.5%
Capital Expenditures

-$23.6M

Previous: -$12.2M-93.8%
Free Cash Flow

$17.9M

Previous: $11.8M+51.4%
Net Income

$41.5M

Previous: $24M+72.9%
Operating Income

$46.4M

Previous: $30M+54.8%
Gross Profit

-$156M

Previous: -$152M-2.7%
Cash & Equivalents

$219M

Previous: $79.3M+176.5%
Total Assets

$1.3B

Previous: $1.07B+20.9%
Stock-Based Comp

$2.76M

Previous: $9.47M-70.8%

Revenue & EPS history

Medpace · Revenue · Quarterly

$230M

Q3 2020+6.5%vs Q3 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Forward guidance

The Company forecasts 2020 revenue in the range of $880.0 million to $920.0 million. GAAP net income for full year 2020 is forecasted in the range of $136.0 million to $144.0 million. Additionally, full year 2020 EBITDA is expected in the range of $180.0 million to $190.0 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-1.7%

Avg return

Earnings day

-1.6%

Avg return

5 days after

+1.1%

Avg return

30 days after

44%

19 / 43 earnings

Positive

+39.0%

Q3 2022

Best reaction

-31.5%

Q1 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.5%-19.4%-14.9%
Q4 2025-15.9%-19.3%-16.3%
Q3 2025+9.0%+6.2%+8.2%
Q2 2025-0.2%+1.5%+7.0%
Q1 2025-2.3%+3.3%+1.4%
Q4 2024-7.5%-4.0%-10.3%
Q3 2024-8.4%-7.3%-8.5%
Q2 2024-15.2%-9.5%-6.1%
Q1 2024+9.4%+6.4%+4.8%
Q4 2023+11.6%+20.0%+25.0%
Q3 2023+18.8%+9.2%+20.8%
Q2 2023+4.6%+3.9%+1.8%
Q1 2023+10.2%+5.9%+7.2%
Q4 2022-2.9%-7.6%-20.4%
Q3 2022+39.0%+41.5%+39.2%
Q2 2022-2.9%+5.0%+3.8%
Q1 2022-12.0%-11.3%-12.2%
Q4 2021-20.6%-18.2%-12.1%
Q3 2021+13.9%+21.1%+14.4%
Q2 2021-6.0%-3.4%-0.8%
Q1 2021-12.8%-11.3%-13.3%
Q4 2020-2.7%-5.3%-2.0%
Q3 2020-6.1%-4.8%+4.4%
Q2 2020+15.5%+12.8%+16.7%
Q1 2020-2.5%-11.9%+9.0%
Q4 2019+2.4%-9.7%-31.7%
Q3 2019+0.8%-0.5%+3.8%
Q2 2019+24.9%+19.9%+27.2%
Q1 2019-4.3%-1.6%-4.7%
Q4 2018-21.3%-21.8%-18.4%
Q3 2018+0.2%+13.9%+21.8%
Q2 2018+28.6%+24.4%+23.4%
Q1 2018+2.3%-0.0%+12.9%
Q4 2017-15.7%-14.3%-5.3%
Q3 2017+6.2%+5.6%-3.7%
Q2 2017+8.0%+15.1%+17.2%
Q1 2016-31.5%-29.1%-12.6%
Q1 2017-29.1%-27.5%-12.3%
Q4 2014-21.3%-20.7%-22.2%
Q2 2016-21.3%-20.7%-22.2%
Q4 2016-19.8%-20.1%-22.3%
Q3 2016+3.8%+8.1%+24.0%
Q4 2015+3.8%+8.1%+24.0%
Q3 2015
Q2 2015
Q1 2015
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro